MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: An experimental study in rats with carbon tetrachloride intoxication

European Radiology

Volumn 22, Issue 8, 2012, Pages 1709-1716

  Zhao, Feng ^a   Wang, Yi Xiang J ^a   Yuan, Jing ^a   Deng, Min ^a   Wong, Hing Lok ^b   Chu, Eagle S H ^b   Go, Minnie Y Y ^b   Teng, Gao Jun ^c   Ahuja, Anil T ^a   Yu, Jun ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

CCl 4; Imaging biomarker; Liver cirrhosis; Liver fibrosis; T1

Indexed keywords

CARBON TETRACHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE COURSE; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER INJURY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; T1RHO;

ANIMALS; BIOLOGICAL MARKERS; CARBON TETRACHLORIDE; DISEASE PROGRESSION; INFLAMMATION; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864690011     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2419-0     Document Type: Article

References (49)

1. Davis GL, Albright JE, Cook SF, Rosenberg DM (2003) Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 9:331-338
2. Charlton M (2004) Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2:1048-1058
3. Zhou K, Lu LG (2009) Assessment of fibrosis in chronic liver diseases. J Dig Dis 10:7-14
4. Wallace K, Burt AD, Wright MC (2008) Liver fibrosis. Biochem J 411:1-18
5. Wanless IR, Nakashima E, Sherman M (2000) Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 124:1599-1607
6. Arthur MJ (2002) Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 122:1525-1528
7. Veldhuijzen IK, Toy M, Hahné SJ, De Wit GA, Schalm SW, de Man RA, Richardus JH (2010) Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology 138:522-530
8. Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmundson S, Condreay LD, Chien RN, Asia Hepatitis Lamivudine Study Group (2001) Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33:1527-1532
9. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Fléjou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, Lévy P (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418-423
10. Oh MK, Winn J, Poordad F (2008) Review article: diagnosis and treatment of non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 28:503-522
11. Asadullah K, Sterry W, Volk HD (2003) Interleukin-10 therapy-review of a new approach. Pharmacol Rev 55:241-269
12. Huang YH, Shi MN, Zheng WD, Zhang LJ, Chen ZX, Wang XZ (2006) Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats. World J Gastroenterol 12:1386-1391
13. Friedman SL (2008) Hepatic fibrosis-overview. Toxicology 254 (3):120-9
14. Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99:1160-1174
15. Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL (2008) Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 47:332-342
16. Janes CH, Lindor KD (1993) Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 118:96-98
17. Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, Schiff ER (1996) The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 43:568-571
18. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, LIDO Study Group (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898-1906
19. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495-500
20. Friedman SL, Bansal MB (2006) Reversal of hepatic fibrosis: fact or fantasy? Hepatology 43(Suppl):S82-S88
21. Wang YX, Yuan J, Chu ES, Go MY, Huang H, Ahuja AT, Sung JJ, Yu J (2011) T1?MRimaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology 259:712-719
22. Sirlin CB (2011) Science to practice: can t1? imaging be used to diagnose and assess the severity of hepatic fibrosis? Radiology 259:619-620
23. Constandinou C, Henderson N, Iredale JP (2005) Modeling liver fibrosis in rodents. Methods Mol Med 117:237-250
24. Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539-548
25. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 102:538-549
26. Charagundla SR, Borthakur A, Leigh JS, Reddy R (2003) Artifacts in T(1rho)-weighted imaging: correction with a self-compensating spin-locking pulse. J Magn Reson 162:113-121
27. Witschey WR, Borthakur A, Elliott MA, Fenty M, Sochor MA, Wang C, Reddy R (2008) T1rho-prepared balanced gradient echo for rapid 3D T1rho MRI. J Magn Reson Imaging 28:744-754
28. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB (2006) Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 239:425-437
29. Salameh N, Larrat B, Abarca-Quinones J, Pallu S, Dorvillius M, Leclercq I, Fink M, Sinkus R, Van Beers BE (2009) Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology 253:90-97
30. Bonekamp S, Kamel I, Solga S, Clark J (2009) Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 50:17-35
31. Cheung JS, Fan SJ, Gao DS, Chow AM, Man K, Wu EX (2010) Diffusion tensor imaging of liver fibrosis in an experimental model. J Magn Reson Imaging 32:1141-1148
32. Santyr GE, Henkelman RM, Bronskill MJ (1989) Spin locking for magnetic resonance imaging with application to human breast. Magn Reson Med 12:25-37
33. Akella SV, Regatte RR, Gougoutas AJ, Borthakur A, Shapiro EM, Kneeland JB, Leigh JS, Reddy R (2001) Proteoglycan induced changes in T1 ?-relaxation of articular cartilage at 4T. Magn Reson Med 46:419-423
34. Szyperski T, Luginbühl P, Otting G, Güntert P, Wüthrich K (1993) Protein dynamics studied by rotating frame 15N spin relaxation times. J Biomol NMR 3:151-164
35. Knispel RR, Thompson RT, Pintar MM (1974) Dispersion of proton spin-lattice relaxation in tissues. J Magn Reson 14:44-51
36. Duvvuri U, Goldberg AD, Kranz JK, Hoang L, Reddy R, Wehrli FW, Wand AJ, Englander SW, Leigh JS (2001) Water magnetic relaxation dispersion in biological systems: the contribution of proton exchange and implications for the noninvasive detection of cartilage degradation. Proc Natl Acad Sci USA 98:12479-12484
37. Nguyen AM, Johannessen W, Yoder JH, Wheaton AJ, Vresilovic EJ, Borthakur A, Elliott DM (2008) Noninvasive quantification of human nucleus pulposus pressure with use of T1rho-weighted magnetic resonance imaging. J Bone Joint Surg (Am) 90:796-802
38. HarisM, McArdle E, Fenty M, Singh A, Davatzikos C, Trojanowski JQ, Melhem ER, Clark CM, Borthakur A (2009) Early marker for Alzheimer's disease: hippocampus T1rho estimation. J Magn Reson Imaging 29:1008-1012
39. Nestrasil I, Michaeli S, Liimatainen T, Rydeen CE, Kotz CM, Nixon JP, Hanson T, Tuite PJ (2010) T1rho and T2rho MRI in the evaluation of Parkinson's disease. J Neurol 257:964-968
40. Fleiss JL (1986) Reliability of measurement. The design and analysis of clinical experiments. Wiley, New York
41. Deng M, Zhao F, Yuan J, Ahuja AT, Wang YX (2012) Liver MR T1? measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence. Br J Radiol. doi:10.1259/bjr/98745548
42. Hazle JD, Narayana PA, Dunsford HA (1990) Chronic carbon tetrachloride and phospholipase D hepatotoxicity in rat: in vivo 1H magnetic resonance, total lipid analysis, and histology. Magn Reson Med 15:211-228
43. Proctor E, Chatamra K (1983) Controlled induction of cirrhosis in the rat. Br J Exp Pathol 64:320-30
44. Wang YX, Yan SX (2008) Biomedical imaging in the safety evaluation of new drugs. Lab Anim 42:433-441
45. Wang YX (2010) In vivo biomedical imaging and spectroscopy in toxicogenomics and toxicoproteomics. Mol Cell Toxicol 6 (Suppl):28
46. Wang H, Li J, Chen F, De Keyzer F, Yu J, Feng Y, Nuyts J, Marchal G, Ni Y (2010) Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours. Eur Radiol 20:2013-26
47. Chen F, Sun X, De Keyzer F, Yu J, Peeters R, Coudyzer W, Vandecaveye V, Landuyt W, Bosmans H, Van Hecke P, Marchal G, Ni Y (2006) Liver tumor model with implanted rhabdomyosarcoma in rats: MR imaging, microangiography, and histopathologic analysis. Radiology 239:554-562
48. Johannessen W, Auerbach J, Wheaton AJ, Kurji A, Reddy R, Borthakur A, Elliott DM (2006) Assessment of human disc degeneration and proteoglycan content using T1rho MRI. Spine (Phila Pa 1976) 31:1253-1257
49. Tsukamoto H, Matsuoka M, French SW (1990) Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10:56-65